Dr. Omar Harfouch, MD

Dr. Harfouch practices at University of Maryland Medical Group - Infectious Disease in Columbia, Maryland.

Dr. Harfouch's NPI, 1063948149, was assigned on May 10, 2017. Dr. Harfouch holds Maryland license D92733.

Dr. Harfouch's primary practice is University of Maryland Medical Group - Infectious Disease, at 5890 Waterloo Rd, Columbia, MD 21045 in Howard County. The practice phone is (410) 328-8040.

Dr. Harfouch's primary practice is University of Maryland Medical Group - Infectious Disease in Columbia, Maryland. Dr. Harfouch is also affiliated with University of Maryland Medical Center. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology. Dmand AI also links Dr. Harfouch to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harfouch practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Harfouch's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Harfouch is licensed in Maryland.

CMS data shows 230 Medicare services from Dr. Harfouch across 4 procedure codes in 2024, for 96 Medicare patients. Medicare paid $21,561 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 96 Medicare patients who saw Dr. Harfouch in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 57% are also on Medicaid. Their average risk score is 4.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Harfouch's median patient age at 50, with 28% women.

In 2024, Dr. Harfouch wrote 427 Medicare Part D claims for 21 patients. 51% of them were for generic drugs. CMS names the drug for 245 of them, across 9 drugs with 11 or more claims each, at $476,319 in total drug cost. In 2023, CMS named 278 claims across 15 drugs.

Dr. Harfouch accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Harfouch from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $16.